3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
NET
1
Lymphoid
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Neoplasms by Site
3
Neoplasms
3
Lymphoma, Large-Cell, Anaplastic
3
Neoplasms by Histologic Type
2
Lymphoproliferative Disorders
2
Hematologic Neoplasms
2
Carcinoma, Renal Cell
2
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Thoracic Neoplasms
1
Sarcoma
1
Salivary Gland Neoplasms
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neuroendocrine Tumors
1
Neuroblastoma
1
Melanoma
1
Lymphoma
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Head and Neck Neoplasms
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Colorectal Neoplasms
1
Colonic Diseases
1
Cholangiocarcinoma
1
Interventions
pembrolizumab
7
Nivolumab
3
Drug Therapy
3
Biopsy, Fine-Needle
3
epacadostat
2
Thiotepa
2
Nonlinear Optical Microscopy
2
Ipilimumab
2
Gemcitabine
2
Filgrastim
2
Cytological Techniques
2
Cyclophosphamide
2
Blood Specimen Collection
2
vocimagene amiretrorepvec
1
tanespimycin
1
spartalizumab
1
motexafin gadolinium
1
fludarabine
1
entrectinib
1
belinostat
1
atezolizumab
1
alectinib
1
aldesleukin
1
Valganciclovir
1
Topotecan
1
Tomography, Emission-Computed
1
Tissue Banks
1
Sirolimus
1
SUB1 protein, human
1
Rituximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
alectinib
×
Lymphoid
×
Clear all
NCT04644315
2023-08-07
ALpha-T
Hoffmann-La Roche
Phase 2
Terminated
1 enrolled
5 charts